PF4 and COVID-19: PF4-dependent platelet-activating antibodies are transient in most patients with VITT [55]; in addition, HIT ELISA reactivity alone has been directly associated with COVID-19 severity in a cohort of 65 hospitalized patients without any evidence of HIT/VITT [56].